Journal of Cardiac Failure
Volume 14, Issue 5 , Pages 400-406 , June 2008

Inotropic Agents Improve the Peripheral Microcirculation of Patients With End-Stage Chronic Heart Failure

  • Serafim Nanas, MD

      Affiliations

    • Pulmonary and Critical Care Medicine Department, Cardiopulmonary Exercise Testing and Rehabilitation Laboratory, “Evgenidio” Hospital
    • Corresponding Author InformationReprint requests: Serafim Nanas, MD, Pulmonary and Critical Care Medicine Department, Cardiopulmonary Exercise Testing and Rehabilitation Laboratory, “Evgenidio Hospital,” National and Kapodestrian University of Athens 20, Papadiamantopoulou St, Athens, 11528, Greece.
    • ,
  • Vasiliki Gerovasili, MD

      Affiliations

    • Pulmonary and Critical Care Medicine Department, Cardiopulmonary Exercise Testing and Rehabilitation Laboratory, “Evgenidio” Hospital
    • ,
  • Stavros Dimopoulos, MD

      Affiliations

    • Clinical Therapeutics Department, “Alexandra” Hospital, National and Kapodestrian University of Athens, Greece
    • ,
  • Charalampos Pierrakos, MD

      Affiliations

    • Clinical Therapeutics Department, “Alexandra” Hospital, National and Kapodestrian University of Athens, Greece
    • ,
  • Soultana Kourtidou, MD

      Affiliations

    • Pulmonary and Critical Care Medicine Department, Cardiopulmonary Exercise Testing and Rehabilitation Laboratory, “Evgenidio” Hospital
    • ,
  • Elissavet Kaldara, MD

      Affiliations

    • Clinical Therapeutics Department, “Alexandra” Hospital, National and Kapodestrian University of Athens, Greece
    • ,
  • Serafim Sarafoglou, MD

      Affiliations

    • Clinical Therapeutics Department, “Alexandra” Hospital, National and Kapodestrian University of Athens, Greece
    • ,
  • John Venetsanakos, MD

      Affiliations

    • Clinical Therapeutics Department, “Alexandra” Hospital, National and Kapodestrian University of Athens, Greece
    • ,
  • Charis Roussos, MD, MRCP, PhD

      Affiliations

    • Pulmonary and Critical Care Medicine Department, Cardiopulmonary Exercise Testing and Rehabilitation Laboratory, “Evgenidio” Hospital
    • ,
  • John Nanas, MD, PhD

      Affiliations

    • Clinical Therapeutics Department, “Alexandra” Hospital, National and Kapodestrian University of Athens, Greece
    • ,
  • Maria Anastasiou-Nana, MD

      Affiliations

    • Clinical Therapeutics Department, “Alexandra” Hospital, National and Kapodestrian University of Athens, Greece

Received 1 November 2006 ,Revised 23 January 2008 ,Accepted 1 February 2008.

References 

  1. Zelis R, Mason DT, Braunwald E. A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. J Clin Invest. 1968;47:960–970
  2. Zelis R, Sinoway LI, Musch TI, Davis D, Just H. Regional blood flow in congestive heart failure: concept of compensatory mechanisms with short and long time constants. Am J Cardiol. 1988;62:2E–8E
  3. Sullivan MJ, Knight JD, Higginbotham MB, Cobb FR. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation. 1989;80:769–781
  4. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ. Plasma endothelin in chronic heart failure. Circulation. 1992;85:1374–1379
  5. Drexler H, Hayoz D, Munzel T, Hornig B, Just H, Brunner HR, et al. Endothelial function in chronic congestive heart failure. Am J Cardiol. 1992;69:1596–1601
  6. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation. 1991;84:1589–1596
  7. Wilson JR, Fink L, Maris J, Ferraro N, Power-Vanwart J, Eleff S, et al. Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance. Circulation. 1985;71:57–62
  8. Lipkin DP, Jones DA, Round JM, Poole-Wilson PA. Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol. 1988;18:187–195
  9. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation. 1990;81:518–527
  10. Duscha BD, Kraus WE, Keteyian SJ, Sullivan MJ, Annex BH. Capillary density of skeletal muscle: a contributing mechanism in class II-III chronic heart failure independent of other peripheral alterations. J Am Coll Cardiol. 1999;33:1956–1963
  11. Xu L, Poole DC, Musch TI. Effect of heart failure on muscle capillary geometry: implications for O2 exchange. Med Sci Sports Exerc. 1998;30:1230–1237
  12. Clark AL, Poole-Wilson PA. Exercise limitation in chronic heart failure: central role of periphery. J Am Coll Cardiol. 1996;28:1092–1102
  13. Franciosa JA, Park M, Levine TB. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol. 1981;47:33–39
  14. Cowley AJ, Fullwood LJ, Muller AF, Stainer K, Skene AM, Hampton JR. Exercise capability in heart failure: is cardiac output important after all?. Lancet. 1991;337:771–773
  15. Sorensen VB, Wroblewski H, Galatius S, Norgaard T, Haunso , Kastrup J. Skin microvascular distensibility and structural microangiopathy in idiopathic dilated cardiomyopathy and after heart transplantation. Microvasc Res. 1999;57:44–51
  16. De Backer D, Creteur J, Dubois MJ, Sakr Y, Vincent JL. Microvascular alterations in patients with acute severe heart failure and cardiogenic shock. Am Heart J. 2004;147:91–99
  17. Andersson SE, Edvinsson ML, Alving K, Edvinsson L. Vasodilator effect of endothelin in cutaneous microcirculation of heart failure patients. Basic Clin Pharmacol Toxicol. 2005;97:80–85
  18. Andersson SE, Edvinsson ML, Edvinsson L. Cutaneous vascular reactivity is reduced in aging and in heart failure: association with inflammation. Clin Sci (Lond). 2003;105:699–707
  19. Miyamoto M, Kishimoto C, Shioji K, Lee JD, Shimizu H, Ueda T, et al. Cutaneous arteriolar thioredoxin expression in patients with heart failure. Circ J. 2003;67:116–118
  20. Nanas JN, Kontoyannis DA, Alexopoulos GP, Anastasiou-Nana MI, Tsagalou EP, Stamatelopoulos SF, et al. Long-term intermittent dobutamine infusion combined with oral amiodarone improves the survival of patients with severe congestive heart failure. Chest. 2001;119:1173–1178
  21. Nanas JN, Tsagalou EP, Kanakakis J, Nanas SN, Terrovitis JV, Moon T, et al. Long-term intermittent dobutamine infusion, combined with oral amiodarone for end-stage heart failure: a randomized double-blind study. Chest. 2004;125:1198–2004
  22. Lopez-Candales AL, Carron C, Schwartz J. Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes. Clin Cardiol. 2004;27:23–28
  23. Cesario D, Clark J, Maisel A. Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study. Am Heart J. 1998;135:121–129
  24. Dean AS, Margulies KB, Nicholas JJ, Rubin S, Gaughan J, Libonati J. Impaired vasoreactivity in end-stage heart failure patients on intravenous inotropic support. J Card Fail. 2005;11:351–357
  25. Nanas JN, Papazoglou P, Tsagalou EP, Ntalianis A, Tsolakis E, Terrovitis JV, et al. Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone. Am J Cardiol. 2005;95:768–771
  26. Nanas JN, Papazoglou PP, Terrovitis JV, Kanakakis J, Dalianis A, Tsolakis E, et al. Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone. Am J Cardiol. 2004;94:1329–1332
  27. Lima A, Bakker J. Noninvasive monitoring of peripheral perfusion. Intensive Care Med. 2005;31:1316–1326
  28. Boushel R, Langberg H, Olesen J, Gonzales-Alonzo J, Bulow J, Kjaer M. Monitoring tissue oxygen availability with near infrared spectroscopy NIRS in health and disease. Scand J Med Sci Sports. 2001;11:213–222
  29. Wahr JA, Tremper KK, Samra S, Delpy DT. Near-infrared spectroscopy: theory and applications. J Cardiothorac Vasc Anesth. 1996;10:406–418
  30. Myers DE, Cooper CE, Beilman GJ, Mowlem JD, Anderson LD, Seifert RP, et al. Noninvasive method for measuring local hemoglobin oxygen saturation in tissue using wide gap second derivative near-infrared spectroscopy. J Biomed Opt. 2005;10:034017
  31. Siafaka A, Angelopoulos E, Kritikos K, Poriazi M, Basios N, Gerovasili V, et al. Acute effects of smoking on skeletal muscle microcirculation monitored by near-infrared spectroscopy. Chest. 2007;131:1479–1485
  32. Hogan CJ, Hess ML, Ward KR, Gennings C. The utility of microvascular perfusion assessment in heart failure: a pilot study. J Card Fail. 2005;11:713–719
  33. Wilson JR, Mancini DM, McCully K, Ferraro N, Lanoce V, Chance B. Noninvasive detection of skeletal muscle underperfusion with near infrared spectroscopy in patients with heart failure. Circulation. 1989;80:1668–1674
  34. Matsui S, Tamura N, Hirakawa T, Kobayashi S, Takekoshi N, Murakami E. Assessment of working skeletal muscle oxygenation in patients with chronic heart failure. Am Heart J. 1995;129:690–695
  35. Belardinelli R, Barstow TJ, Nguyen P, Wasserman K. Skeletal muscle oxygenation and oxygen uptake kinetics following constant work rate exercise in chronic congestive heart failure. Am J Cardiol. 1997;80:1319–1324
  36. Podbregar M, Mozina H. Skeletal muscle oxygen saturation does not estimate mixed venous oxygen saturation in patients with severe left heart failure and additional severe sepsis or septic shock. Crit Care. 2007;11:R6
  37. Pareznik R, Knezevic R, Voga G, Podbregar M. Changes in muscle tissue oxygenation during stagnant ischemia in septic patients. Intensive Care Med. 2006;32:87–92
  38. Doerschug KC, Delsing AS, Schmidt GA, Haynes WG. Impairments in microvascular reactivity are related to organ failure in human sepsis. Am J Physiol Heart Circ Physiol. 2007;293:H1065–H1071Epub 2007 May 4
  39. Patel MB, Kaplan IV, Patni RN, Levy D, Strom JA, Shirani J, et al. Sustained improvement in flow-mediated vasodilation after short-term administration of dobutamine in patients with severe congestive heart failure. Circulation. 1999;99:60–64
  40. Freimark D, Feinberg MS, Matezky S, Hochberg N, Shechter M. Impact of short-term intermittent intravenous dobutamine therapy on endothelial function in patients with severe chronic heart failure. Am Heart J. 2004;148:878–882
  41. Mancini DM, Schwartz M, Ferraro N, Seestedt R, Chance B, Wilson JR. Effect of dobutamine on skeletal muscle metabolism in patients with congestive heart failure. Am J Cardiol. 1990;65:1121–1126
  42. Lilleberg J, Laine M, Palkama T, Kivikko M, Pohjanjousi P, Kupari M. Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure. Eur J Heart Fail. 2007;9:75–82Epub 2006 Jul 7
  43. Nieminen MS, Akkila J, Hasenfuss G, Kleber FX, Lehtonen LA, Mitrovic V, et al. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. J Am Coll Cardiol. 2000;36:1903–1912
  44. Slawsky MT, Colucci WS, Gottlieb SS, Greenberg BH, Haeusslein E, Hare J, et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation. 2000;102:2222–2227
  45. Parissis JT, Adamopoulos S, Antoniades C, Kostakis G, Rigas A, Kyrzopoulos S, et al. Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure. Am J Cardiol. 2004;93:1309–1312
  46. Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ, et al. SURVIVE Investigators. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA. 2007;297:1883–1891

 This study was partly funded by grant from the Special Account for Research Grants of the National and Kapodistrian University of Athens, Greece, and by the Thorax Foundation.

PII: S1071-9164(08)00066-3

doi: 10.1016/j.cardfail.2008.02.001

Journal of Cardiac Failure
Volume 14, Issue 5 , Pages 400-406 , June 2008

Article Tools

* Image Usage & Resolution